Launched in September 2012 a year after the company was founded, the bioinformatics tool of Sophia Genetics is being used by 12 hospitals and laboratories in Switzerland.
Sophia Genetics, a Switzerland-based human gene bank spun of out of the local Federal Institute of Technology Lausanne (EPFL), has raised SFr2.8m ($2.8m) from undisclosed investors. Launched in September 2012 a year after the company was founded, the bioinformatics tool of Sophia Genetics is being used by 12 hospitals and laboratories in Switzerland.
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
